360Dx

NeoGenomic Redeems Series A Redeemable Preferred Stock for $50.1M

Jun 25, 2018

NEW YORK (GenomeWeb) – NeoGenomics announced after the close of the market on Monday that it has redeemed 6,864,000 million shares of Series A Redeemable Preferred Stock held by an affiliate of General Electric Company for approximately $50.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

NeoGenomic Redeems Series A Redeemable Preferred Stock for $50.1M

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

Featured White Papers

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

What's Popular?

Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

FDA Grants First ASCA Accreditations to Labs to Perform Premarket Testing

Sponsorships